William R Jellison Anika Therapeutics, Inc. (ANIK) insider trading activity

William R Jellison is Director of Anika Therapeutics, Inc.. Currently has a direct ownership of 20,403 shares of ANIK, which is worth approximately $199,541. The most recent transaction as insider was on Jun 20, 2025, when has been sold 14,164 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.4K

0% 3M change

227.02% 12M change

Total Value Held $199,541

William R Jellison Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2025	BUY Grant, award, or other acquisition	-	14,164 Added 40.98%	20,403 Common Stock
Jul 09 2024	BUY Grant, award, or other acquisition	-	5,771 Added 48.05%	6,239 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	-	468 Added 12.87%	3,168 Common Stock

Also insider at

AVNT

AVIENT CORP Basic Materials

Director

MASI

MASIMO CORP Healthcare

Director

MDT

Medtronic plc Healthcare

Director

WRJ